HopeStage
Back to all studies
CompletedNCT00205660

Weight and metabolism when continuing treatment or switching to aripiprazole in schizophrenia

About this titleRead the official source — NCT00205660
Interventional studyAges 18–60United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
St LouisSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2005
Recruitment status
Completed
Enrollment listed in the registry
51
Sponsor
Washington University School of Medicine
Sponsor type
University
Study type
Other
Intervention type
Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT00205660
Official title
Show the full official title

Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St Louis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Washington University School of Medicine, a university.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies